Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies

키워드

참고문헌 (104)

1. Chimowitz MI, "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis", N Engl J Med, 352, pp.1305~1316 (2005)
2. Bhatt DL, "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events", N Engl J Med, 354, pp.1706~1717 (2006)
3. Adams HP Jr, "Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)", Stroke, 39, pp.87~99 (2008)
4. Shuaib A, "NXY-059 for the treatment of acute ischemic stroke", N Engl J Med, 357, pp.562~571 (2007)
5. Caplan LR, "Evidence based medicine: concerns of a clinical neurologist", J Neurol Neurosurg Psychiatry, 71, pp.569~574 (2001)
6. McAlister FA, "Users’ guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group", JAMA, 283, pp.2829~2836 (2000)
7. Cook RJ, "The number needed to treat: a clinically useful measure of treatment effect", BMJ, 310, pp.452~454 (1995)
8. Tissue plasminogen activator for acute ischemic stroke, "The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group", N Engl J Med, 333, pp.1581~1587 (1995)
9. Saver JL, "Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke", Arch Neurol, 61, pp.1066~1070 (2004)
10. Saver JL, "Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm", Stroke, 38, pp.2279~2283 (2007)
11. Fierz W, "Challenge of personalized health care: to what extent is medicine already individualized and what are the future trends?", Med Sci Monit, 10, pp.RA111~RA123 (2004)
12. Donnan GA, "Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy", Lancet Neurol, 1, pp.417~425 (2002)
13. Tanne D, "Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group", Neurology, 53, pp.424~427 (1999)
14. Clark WM, "Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. in: Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke", JAMA, 282, pp.2019~2026 (1999)
15. Hacke W, "Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials", Lancet, 363, pp.768~774 (2004)
16. Marler JR, "Early stroke treatment associated with better outcome: the NINDS rt- PA stroke study", Neurology, 55, pp.1649~1655 (2000)
17. Adams HP Jr, "Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association", American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists, 2007, pp.38, 1655~1711
18. Lindsberg PJ, "Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment", Neurology, 67, pp.334~336 (2006)
19. Molina CA, "Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies", Stroke, 36, pp.2311~2320 (2005)
20. Heiss WD, "Penumbra and irreversible damage in acute ischemic stroke: comparison of diffusion- and perfusion-weighted mangetic resonance imaging and positron emission tomography", Ann Neurol, 52, pp.S24~ (2002)
21. Darby DG, "Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI", Stroke, 30, pp.2043~2052 (1999)
22. Hacke W, "The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase", Stroke, 36, pp.66~73 (2005)
23. Furlan AJ, "Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset", Stroke, 37, pp.1227~1231 (2006)
24. Hjort N, "Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct", Stroke, 36, pp.388~397 (2005)
25. Köhrmann M, "MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study", Lancet Neurol, 5, pp.661~667 (2006)
26. Kidwell CS, "Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging", Stroke, 34, pp.2729~2735 (2003)
27. Albers GW, "Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study", Ann Neurol, 60, pp.508~517 (2006)
28. Olivot JM, "Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE)", Stroke, 39, pp.2257~2263 (2008)
29. Bang OY, "Impact of collateral flow on tissue fate in acute ischaemic stroke", J Neurology Neurosurg psychiatry, 79, pp.625~629 (2008)
30. Liebeskind DS, "Collateral circulation", Stroke, 34, pp.2279~2284 (2003)
31. Christoforidis GA, "Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke", AJNR Am J Neuroradiol, 26, pp.1789~1797 (2005)
32. Christensen S, "Inferring origin of vascular supply from tracer arrival timing patterns using bolus tracking MRI", J Magn Reson Imaging, 27, pp.1371~1381 (2008)
33. Bang OY, "UCLA Collateral Investigators. Determinants of the distribution and severity of hypoperfusion in patients with ischemic stroke", Neurology, 71, pp.1804~1811 (2008)
34. Kim SJ, "MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes", J Cereb Blood Flow Metab, 29, pp.1138~1145 (2009)
35. Heiss WD, "Ischemic penumbra: evidence from functional imaging in man", J Cereb Blood Flow Metab, 20, pp.1276~1293 (2000)
36. Tamura H, "Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2*-weighted magnetic resonance imaging", Stroke, 33, pp.967~971 (2002)
37. Baron JC, "Reversal of focal “misery-perfusion syndrome” by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. in: A case study with 15O positron emission tomography", Stroke, 12, pp.454~459 (1981)
38. Hermier M, "Contribution of susceptibility-weighted imaging to acute stroke assessment", Stroke, 35, pp.1989~1994 (2004)
39. Lee JM, "Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients", Ann Neurol, 53, pp.227~232 (2003)
40. Hermier M, "Hypointense leptomeningeal vessels at T2*-weighted MRI in acute ischemic stroke", Neurology, 65, pp.652~653 (2005)
41. Roussel SA, "Identification of collaterally perfused areas following focal cerebral ischemia in the rat by comparison of gradient echo and diffusion-weighted MRI", J Cereb Blood Flow Metab, 15, pp.578~586 (1995)
42. Gröhn OH, "Noninvasive detection of cerebral hypoperfusion and reversible ischemia from reductions in the magnetic resonance imaging relaxation time, T2", J Cereb Blood Flow Metab, 18, pp.911~920 (1998)
43. Ogawa S, "Brain magnetic resonance imaging with contrast dependent on blood oxygenation", Proc Natl Acad Sci U S A, 통권 : 87, pp.9868~9872 (1990)
44. Geisler BS, "Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients", Stroke, 37, pp.1778~1784 (2006)
45. Hermier M, "Hypointense transcerebral veins at T2*-weighted MRI: a marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator", J Cereb Blood Flow Metab, 23, pp.1362~1370 (2003)
46. Marchal G, "Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxelbased data analysis", Stroke, 27, pp.599~606 (1996)
47. Kane I, "Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion", perfusion mismatch, clinical scores, and radiologic outcomes, 2007, pp.38, 3158~3164
48. Wu O, "Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging", Stroke, 32, pp.933~942 (2001)
49. Kakuda W, "Optimal definition for PWI", DWI mismatch in acute ischemic stroke patients, 2008, pp.28, 887~891
50. Toth G, "Use of MRI to Estimate the Therapeutic Window in Acute Stroke: is perfusion-weighted imaging", diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue?, 2009, pp.40, 333~335
51. Kidwell CS, "Comparison of MRI and CT for detection of acute intracerebral hemorrhage", JAMA, 292, pp.1823~1830 (2004)
52. Singer OC, "Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging", Ann Neurol, 63, pp.52~60 (2008)
53. Selim M, "Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume", Stroke, 33, pp.2047~2052 (2002)
54. Alsop DC, "Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke", Stroke, 36, pp.746~750 (2005)
55. Neumann-Haefelin T, "Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke", Stroke, 37, pp.2463~2466 (2006)
56. Kim EY, "Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion- weighted imaging and early parenchymal enhancement", AJNR Am J Neuroradiol, 26, pp.1050~1055 (2005)
57. Latour LL, "Early blood-brain barrier disruption in human focal brain ischemia", Ann Neurol, 56, pp.468~477 (2004)
58. Nagaraja TN, "Step-down infusions of Gd-DTPA yield greater contrastenhanced magnetic resonance images of BBB damage in acute stroke than bolus injections", Magn Reson Imaging, 25, pp.311~318 (2007)
59. Provenzale JM, "Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging", AJR Am J Roentgenol, 178, pp.711~716 (2002)
60. Cha S, "Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas", AJNR Am J Neuroradiol, 27, pp.409~417 (2006)
61. Kassner A, "Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging", AJNR Am J Neuroradiol, 26, pp.2213~2217 (2005)
62. Bang OY, "Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging", Ann Neurol, 62, pp.170~176
63. Lin K, "Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging", AJNR Am J Neuroradiol, 28, pp.1292~1298 (2007)
64. Bang OY, "Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke", Stroke, 40, pp.454~461 (2009)
65. Lev MH, "CT", NIHSS mismatch for detection of salvageable brain in acute stroke triage beyond the 3-hour time window: overrated or undervalued?, 2007, pp.38, 2028~2029
66. Hillis AE, "Site of the ischemic penumbra as a predictor of potential for recovery of functions", Neurology, 71, pp.184~189 (2008)
67. Lee LJ, "Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography", Stroke, 31, pp.1081~1089 (2000)
68. Roh JK, "Significance of acute multiple brain infarction on diffusion-weighted imaging", Stroke, 31, pp.688~694 (2000)
69. Bang OY, "DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory", J Neurol Neurosurg Psychiatry, 76, pp.1222~1228 (2005)
70. Fisher M, "Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke", Neurology, 52, pp.1750~1756 (1999)
71. Kimura K, "Microembolic signals and diffusion-weighted MR imaging abnormalities in acute ischemic stroke", AJNR Am J Neuroradiol, 22, pp.1037~1042 (2001)
72. Lansberg MG, "Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke", AJNR Am J Neuroradiol, 22, pp.637~644 (2001)
73. Sylaja PN, "VISION Study Group. Acute ischemic lesions of varying ages predict risk of ischemic events in stroke", TIA patients, 2007, pp.68, 415~419
74. Klein I, "Silent T2* cerebral microbleeds: a potential new imaging clue in infective endocarditis", Neurology, 68, pp.2043~ (2007)
75. Singhal AB, "Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion- weighted magnetic resonance imaging study", Stroke, 33, pp.1267~1273 (2002)
76. Jauss M, "Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source", Stroke, 37, pp.2159~2161 (2006)
77. Hayashida K, "Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography", J Nucl Med, 42, pp.859~863 (2001)
78. Bang OY, "Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction", Arch Neurol, 59, pp.259~263 (2002)
79. Bang OY, "The course of patients with lacunar infarcts and a parent arterial lesion: similarities to large artery vs small artery disease", Arch Neurol, 61, pp.514~519 (2004)
80. Cho AH, "Is 15 mm size criterion for lacunar infarction still valid? A study on strictly subcortical middle cerebral artery territory infarction using diffusion-weighted MRI", Cerebrovasc Dis, 23, pp.14~19 (2007)
81. Bang OY, "Clinical MRI cutoff points for predicting lacunar stroke may not exist: need for a grading rather than a dichotomizing system", Cerebrovasc Dis, 24, pp.520~529 (2007)
82. Ay H, "An evidence-based causative classification system for acute ischemic stroke", Ann Neurol, 58, pp.688~697 (2005)
83. Cho ZH, "Observation of the lenticulostriate arteries in the human brain in vivo using 7.0T MR angiography", Stroke, 39, pp.1604~1606 (2008)
84. Jackson C, "Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction", Brain, 128, pp.2507~2517 (2005)
85. Kato H, "Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis", Stroke, 33, pp.1536~1540 (2002)
86. Briley-Saebo KC, "Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes", J Magn Reson Imaging, 26, pp.460~479 (2007)
87. Cai JM, "Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging", Circulation, 106, pp.1368~1373 (2002)
88. Saam T, "Quantitative evaluation of carotid plaque composition by in vivo MRI", Arterioscler Thromb Vasc Biol, 25, pp.234~239 (2005)
89. Choudhury RP, "MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging", Arterioscler Thromb Vasc Biol, 22, pp.1065~1074 (2002)
90. Sirol M, "Lipid-rich atherosclerotic plaques detected by gadofluorineenhanced in vivo magnetic resonance imaging", Circulation, 109, pp.2890~2896 (2004)
91. Kooi ME, "Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging", Circulation, 107, pp.2453~2458 (2003)
92. Trivedi RA, "Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages", Arterioscler Thromb Vasc Biol, 26, pp.1601~1606 (2006)
93. Malek AM, "Hemodynamic shear stress and its role in atherosclerosis", JAMA, 282, pp.20335~2042 (1999)
94. Fuster V, "Atherothrombosis and high-risk plaque: part I: evolving concepts", J Am Coll Cardiol, 46, pp.937~954 (2005)
95. Slager CJ, "The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications", Nat Clin Pract Cardiovasc Med, 2, pp.456~464 (2005)
96. Groen HC, "Plaque rupture in the carotid artery is localized at the high shear stress region: a case report", Stroke, 38, pp.2379~2381 (2007)
97. Chatzizisis YS, "Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior", J Am Coll Cardiol, 49, pp.2379~2393 (2007)
98. Cebral JR, "Characterization of cerebral aneurysms for assessing risk of rupture by using patient-specific computational hemodynamics models", AJNR Am J Neuroradiol, 26, pp.2550~2559 (2005)
99. Glagov S, "Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries", Arch Pathol Lab Med, 112, pp.1018~1031 (1988)
100. Zhao SZ, "Inter-individual variations in wall shear stress and mechanical stress distributions at the carotid artery bifurcation of healthy humans", J Biomech, 35, pp.1367~1377 (2002)
101. Papathanasopoulou P, "MRI measurement of time-resolved wall shear stress vectors in a carotid bifurcation model, and comparison with CFD predictions", J Magn Reson Imaging, 17, pp.153~162 (2003)
102. Lee SW, "Geometry of the carotid bifurcation predicts its exposure to disturbed flow", Stroke, 39, pp.2341~2347 (2008)
103. 방오영, "Benign Oligemia Despite a Malignant MRI Profile in Acute Ischemic Stroke", Journal of Clinical Neurology, 6(1), pp.41~45 (2010), 대한신경과학회
104. Bang OY, "MRI for mismatch, deoxygenation, and blood-brainbarrier derangement in acute ischemic stroke. in: Therapeutic Strategies in Cerebral Ischemia", Clinical publishing

관련 논문AI추천